Tuesday, 10 March 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 10 March 2026
News

Who forgot to pay the patent renewal?

Posted 10 March 2026 PM

Bayer and Teva have lost a stoush challenging Cipla's extension of a patent after a ruling that a failure to pay renewal fees on time was due to a genuine error.

IP Australia delegate Greg Powell said he was satisfied some "breakdown in procedure" had occurred which meant the renewal fees were not paid on time to extend a patent titled Combination of azelastine and steroids, owned by Cipla, according to Australian legal publication, Lawyerly.

To see the whole article, please login


Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.